Neurotoxicity Research

Aims & Scope

Neurotoxicity Research is an international, interdisciplinary broad-based journal for reporting both basic and clinical research on classical neurotoxicity effects and mechanisms associated with neurodegeneration, necrosis, neuronal apoptosis, nerve regeneration, neurotrophin mechanisms, and topics related to these themes.

Published papers have focused on: NEURODEGENERATION and INJURY Neuropathologies Neuronal apoptosis Neuronal necrosis Neural death processes (anatomical, histochemical, neurochemical) Neurodegenerative Disorders Neural Effects of Substances of Abuse NERVE REGENERATION and RESPONSES TO INJURY Neural Adaptations Neurotrophin mechanisms and actions NEURO(CYTO)TOXICITY PROCESSES and NEUROPROTECTION Excitatory amino acids Neurotoxins, endogenous and synthetic Reactive oxygen (nitrogen) species Neuroprotection by endogenous and exogenous agents Papers on related themes are welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.3
2024	2.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.831

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	90

Journal Rank

Year	Value
2024	6425

Journal Citation Indicator

Year	Value
2024	1418

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Neuroscience and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

  Citation: 432

  Authors: Masato, Ikuko, Norio

• Dopamine and reward: The anhedonia hypothesis 30 years on

  Citation: 425

  Authors: Roy A.

• The 6-Hydroxydopamine model of parkinson’s disease

  Citation: 409

  Authors: Nicola, Micaela, Anna R.

• The Role of PI3K/Akt and ERK in Neurodegenerative Disorders

  Citation: 388

  Authors: Sachchida Nand, Hagera, Hareram, Saumitra Sen, Walia, Aaina Singh, Brijesh Kumar, Surya Pratap

• Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

  Citation: 257

  Authors: Chris G., Wojciech, Andrzej, Irena

• Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes

  Citation: 256

  Authors: Seithikurippu R., Ahmed S., Gregory M., D. Warren, Vijay K., Charanjit, Rüdiger, Daniel P.

• Endoplasmic Reticulum Stress Plays Critical Role in Brain Damage After Cerebral Ischemia/Reperfusion in Rats

  Citation: 248

  Authors: Venkata Prasuja, Anchal, Ram

• Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

  Citation: 241

  Authors: Steven P., Tariq, Sabine, Jeffrey N.

• Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

  Citation: 229

  Authors: Jean Lud, Irina N., Subramaniam, Johnalyn

• Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

  Citation: 223

  Authors: Wei, Kester, Albert R., Jie, Alberto, Fabio A., Rudolph, Steven Y., David S., Colin F., Belinda, Vernice, Serge, Danielle, John, Jau-Shyong, David, Luigi

---